Dutasteride plus tamsulosin fixed-dose combination first-line therapy versus tamsulosin monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting. [electronic resource]
Producer: 20150407Description: 78 p. digitalISSN:- 1471-2490
- Azasteroids -- economics
- Budgets
- Cost-Benefit Analysis
- Drug Therapy, Combination
- Dutasteride
- Greece
- Humans
- Male
- Middle Aged
- Office Visits -- statistics & numerical data
- Prostatic Hyperplasia -- drug therapy
- Sulfonamides -- economics
- Tamsulosin
- Transurethral Resection of Prostate -- statistics & numerical data
- Urinary Retention -- prevention & control
- Urological Agents -- economics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.